Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

P300 amplitude attenuation in high risk and early onset psychosis youth.

Graber K, Bosquet Enlow M, Duffy FH, D'Angelo E, Sideridis G, Hyde DE, Morelli N, Tembulkar S, Gonzalez-Heydrich J.

Schizophr Res. 2019 Aug;210:228-238. doi: 10.1016/j.schres.2018.12.029. Epub 2019 Jan 23.

PMID:
30685392
2.

Diagnostic Uncertainty in a Complex Young Man: Autism Versus Psychosis.

Fogler J, Kuhn J, Prock L, Radesky J, Gonzalez-Heydrich J.

J Dev Behav Pediatr. 2019 Jan;40(1):72-74. doi: 10.1097/DBP.0000000000000635.

PMID:
30601773
3.

De novo variant of TRRAP in a patient with very early onset psychosis in the context of non-verbal learning disability and obsessive-compulsive disorder: a case report.

Mavros CF, Brownstein CA, Thyagrajan R, Genetti CA, Tembulkar S, Graber K, Murphy Q, Cabral K, VanNoy GE, Bainbridge M, Shi J, Agrawal PB, Beggs AH, D'Angelo E, Gonzalez-Heydrich J.

BMC Med Genet. 2018 Nov 13;19(1):197. doi: 10.1186/s12881-018-0711-9.

4.

Young children with psychotic symptoms and risk for suicidal thoughts and behaviors: a research note.

Sinclair-McBride K, Morelli N, Tembulkar S, Graber K, Gonzalez-Heydrich J, D'Angelo EJ.

BMC Res Notes. 2018 Aug 10;11(1):568. doi: 10.1186/s13104-018-3680-3.

5.

Social impairment and social language deficits in children and adolescents with and at risk for psychosis.

D'Angelo EJ, Morelli N, Lincoln SH, Graber K, Tembulkar S, Gaudet A, Gonzalez-Heydrich J.

Schizophr Res. 2019 Feb;204:304-310. doi: 10.1016/j.schres.2018.07.028. Epub 2018 Aug 1.

PMID:
30077431
6.

De novo ATP1A3 and compound heterozygous NLRP3 mutations in a child with autism spectrum disorder, episodic fatigue and somnolence, and muckle-wells syndrome.

Torres A, Brownstein CA, Tembulkar SK, Graber K, Genetti C, Kleiman RJ, Sweadner KJ, Mavros C, Liu KX, Smedemark-Margulies N, Maski K, Yang E, Agrawal PB, Shi J, Beggs AH, D'Angelo E, Lincoln SH, Carroll D, Dedeoglu F, Gahl WA, Biggs CM, Swoboda KJ, Berry GT, Gonzalez-Heydrich J.

Mol Genet Metab Rep. 2018 Jun 15;16:23-29. doi: 10.1016/j.ymgmr.2018.06.001. eCollection 2018 Sep.

7.

Potentially traumatic events in youth with and at clinical high risk for psychosis.

Morelli N, Fogler J, Tembulkar S, Graber K, Lincoln SH, Bosquet Enlow M, Gonzalez-Heydrich J, D'Angelo EJ.

Early Interv Psychiatry. 2019 Aug;13(4):805-809. doi: 10.1111/eip.12565. Epub 2018 Mar 25.

PMID:
29575640
8.

Suicidal behaviors and their relationship with psychotic-like symptoms in children and adolescents at clinical high risk for psychosis.

D'Angelo EJ, Lincoln SH, Morelli N, Graber K, Tembulkar S, Gonzalez-Heydrich J.

Compr Psychiatry. 2017 Oct;78:31-37. doi: 10.1016/j.comppsych.2017.07.008. Epub 2017 Jul 20.

PMID:
28803039
9.

Review of Salient Investigational Drugs for the Treatment of Fragile X Syndrome.

Munshi K, Pawlowski K, Gonzalez-Heydrich J, Picker JD.

J Child Adolesc Psychopharmacol. 2017 Dec;27(10):850-863. doi: 10.1089/cap.2016.0200. Epub 2017 May 5. Review.

PMID:
28475355
10.

Social cognitive impairment in 22q11 deletion syndrome: A review.

Norkett EM, Lincoln SH, Gonzalez-Heydrich J, D'Angelo EJ.

Psychiatry Res. 2017 Jul;253:99-106. doi: 10.1016/j.psychres.2017.01.103. Epub 2017 Feb 23. Review.

PMID:
28364592
11.

A Developmental Perspective on Social-Cognition Difficulties in Youth at Clinical High Risk for Psychosis.

Lincoln SH, Norkett EM, Frost KH, Gonzalez-Heydrich J, D'Angelo EJ.

Harv Rev Psychiatry. 2017 Jan/Feb;25(1):4-14. doi: 10.1097/HRP.0000000000000125. Review.

PMID:
28059932
12.

Suicidal behaviors in children and adolescents with psychotic disorders.

Lincoln SH, Norkett E, Graber K, Tembulkar S, Morelli N, Gonzalez-Heydrich J, D'Angelo E.

Schizophr Res. 2017 Jan;179:13-16. doi: 10.1016/j.schres.2016.09.020. Epub 2016 Oct 1.

PMID:
27707531
13.

A novel de novo mutation in ATP1A3 and childhood-onset schizophrenia.

Smedemark-Margulies N, Brownstein CA, Vargas S, Tembulkar SK, Towne MC, Shi J, Gonzalez-Cuevas E, Liu KX, Bilguvar K, Kleiman RJ, Han MJ, Torres A, Berry GT, Yu TW, Beggs AH, Agrawal PB, Gonzalez-Heydrich J.

Cold Spring Harb Mol Case Stud. 2016 Sep;2(5):a001008. doi: 10.1101/mcs.a001008.

14.

Overlapping 16p13.11 deletion and gain of copies variations associated with childhood onset psychosis include genes with mechanistic implications for autism associated pathways: Two case reports.

Brownstein CA, Kleiman RJ, Engle EC, Towne MC, D'Angelo EJ, Yu TW, Beggs AH, Picker J, Fogler JM, Carroll D, Schmitt RC, Wolff RR, Shen Y, Lip V, Bilguvar K, Kim A, Tembulkar S, O'Donnell K, Gonzalez-Heydrich J.

Am J Med Genet A. 2016 May;170A(5):1165-73. doi: 10.1002/ajmg.a.37595. Epub 2016 Feb 16.

15.

N100 Repetition Suppression Indexes Neuroplastic Defects in Clinical High Risk and Psychotic Youth.

Gonzalez-Heydrich J, Enlow MB, D'Angelo E, Seidman LJ, Gumlak S, Kim A, Woodberry KA, Rober A, Tembulkar S, O'Donnell K, Hamoda HM, Kimball K, Rotenberg A, Oberman LM, Pascual-Leone A, Keshavan MS, Duffy FH.

Neural Plast. 2016;2016:4209831. doi: 10.1155/2016/4209831. Epub 2016 Jan 12.

16.

Early auditory processing evoked potentials (N100) show a continuum of blunting from clinical high risk to psychosis in a pediatric sample.

Gonzalez-Heydrich J, Bosquet Enlow M, D'Angelo E, Seidman LJ, Gumlak S, Kim A, Woodberry KA, Rober A, Tembulkar S, Graber K, O'Donnell K, Hamoda HM, Kimball K, Rotenberg A, Oberman LM, Pascual-Leone A, Keshavan MS, Duffy FH.

Schizophr Res. 2015 Dec;169(1-3):340-345. doi: 10.1016/j.schres.2015.10.037. Epub 2015 Nov 6.

17.

Neurophysiological differences between patients clinically at high risk for schizophrenia and neurotypical controls--first steps in development of a biomarker.

Duffy FH, D'Angelo E, Rotenberg A, Gonzalez-Heydrich J.

BMC Med. 2015 Nov 2;13:276. doi: 10.1186/s12916-015-0516-z.

18.

Effect of 2 psychotherapies on depression and disease activity in pediatric Crohn's disease.

Szigethy E, Youk AO, Gonzalez-Heydrich J, Bujoreanu SI, Weisz J, Fairclough D, Ducharme P, Jones N, Lotrich F, Keljo D, Srinath A, Bousvaros A, Kupfer D, DeMaso DR.

Inflamm Bowel Dis. 2015 Jun;21(6):1321-8. doi: 10.1097/MIB.0000000000000358.

19.

Epilepsy & behavior: My intellectual home for 15 years!

Gonzalez-Heydrich J.

Epilepsy Behav. 2014 Nov;40:96. doi: 10.1016/j.yebeh.2014.08.127. Epub 2014 Sep 30. No abstract available.

PMID:
25260237
20.

Randomized efficacy trial of two psychotherapies for depression in youth with inflammatory bowel disease.

Szigethy E, Bujoreanu SI, Youk AO, Weisz J, Benhayon D, Fairclough D, Ducharme P, Gonzalez-Heydrich J, Keljo D, Srinath A, Bousvaros A, Kirshner M, Newara M, Kupfer D, DeMaso DR.

J Am Acad Child Adolesc Psychiatry. 2014 Jul;53(7):726-35. doi: 10.1016/j.jaac.2014.04.014. Epub 2014 May 10.

21.

Comparing stimulant effects in youth with ADHD symptoms and epilepsy.

Gonzalez-Heydrich J, Hsin O, Gumlak S, Kimball K, Rober A, Azeem MW, Hickory M, Mrakotsky C, Torres A, Mezzacappa E, Bourgeois B, Biederman J.

Epilepsy Behav. 2014 Jul;36:102-7. doi: 10.1016/j.yebeh.2014.04.026. Epub 2014 Jun 2.

22.

Elevated rates of ADHD in mothers of children with comorbid ADHD and epilepsy.

Gonzalez-Heydrich J, Hamoda HM, Luna L, Rao S, McClendon J, Rotella P, Waber D, Boyer K, Faraone SV, Whitney J, Guild D, Biederman J.

Neuropsychiatry (London). 2012 Oct 1;2(5):385-391.

23.

"RAGE-Control": A Game to Build Emotional Strength.

Kahn J, Ducharme P, Rotenberg A, Gonzalez-Heydrich J.

Games Health J. 2013 Feb;2(1):53-7. doi: 10.1089/g4h.2013.0007.

PMID:
26196556
24.

Management of psychotropic medication side effects in children and adolescents.

Garcia G, Logan GE, Gonzalez-Heydrich J.

Child Adolesc Psychiatr Clin N Am. 2012 Oct;21(4):713-38. doi: 10.1016/j.chc.2012.07.012. Review.

PMID:
23040898
25.

Effects of STX209 (arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: a randomized, controlled, phase 2 trial.

Berry-Kravis EM, Hessl D, Rathmell B, Zarevics P, Cherubini M, Walton-Bowen K, Mu Y, Nguyen DV, Gonzalez-Heydrich J, Wang PP, Carpenter RL, Bear MF, Hagerman RJ.

Sci Transl Med. 2012 Sep 19;4(152):152ra127.

26.

Longitudinal results of cognitive behavioral treatment for youths with inflammatory bowel disease and depressive symptoms.

Thompson RD, Craig A, Crawford EA, Fairclough D, Gonzalez-Heydrich J, Bousvaros A, Noll RB, DeMaso DR, Szigethy E.

J Clin Psychol Med Settings. 2012 Sep;19(3):329-37. doi: 10.1007/s10880-012-9301-8.

PMID:
22699797
27.

Evidence-based treatment approach to autism spectrum disorders.

Munshi KR, Gonzalez-Heydrich J, Augenstein T, D'Angelo EJ.

Pediatr Ann. 2011 Nov;40(11):569-74. doi: 10.3928/00904481-20111007-08. Review. No abstract available.

PMID:
22066509
28.

Tolerability of atomoxetine for treatment of pediatric attention-deficit/hyperactivity disorder in the context of epilepsy.

Torres A, Whitney J, Rao S, Tilley C, Lobel R, Gonzalez-Heydrich J.

Epilepsy Behav. 2011 Jan;20(1):95-102. doi: 10.1016/j.yebeh.2010.11.002. Epub 2010 Dec 13.

PMID:
21146461
29.

The Use of Antiepileptic Drugs (AEDs) for the Treatment of Pediatric Aggression and Mood Disorders.

Munshi KR, Oken T, Guild DJ, Trivedi HK, Wang BC, Ducharme P, Gonzalez-Heydrich J.

Pharmaceuticals (Basel). 2010 Sep 10;3(9):2986-3004. Review.

30.

Adaptive phase I study of OROS methylphenidate treatment of attention deficit hyperactivity disorder with epilepsy.

Gonzalez-Heydrich J, Whitney J, Waber D, Forbes P, Hsin O, Faraone SV, Dodds A, Rao S, Mrakotsky C, Macmillan C, Demaso DR, de Moor C, Torres A, Bourgeois B, Biederman J.

Epilepsy Behav. 2010 Jul;18(3):229-37. doi: 10.1016/j.yebeh.2010.02.022. Epub 2010 May 21.

31.

Use of a virtual community as a psychosocial support system in pediatric transplantation.

Bers MU, Beals LM, Chau C, Satoh K, Blume ED, DeMaso DR, Gonzalez-Heydrich J.

Pediatr Transplant. 2010 Mar;14(2):261-7. doi: 10.1111/j.1399-3046.2010.01271.x.

PMID:
20470360
32.

Transcranial magnetic stimulation provides means to assess cortical plasticity and excitability in humans with fragile x syndrome and autism spectrum disorder.

Oberman L, Ifert-Miller F, Najib U, Bashir S, Woollacott I, Gonzalez-Heydrich J, Picker J, Rotenberg A, Pascual-Leone A.

Front Synaptic Neurosci. 2010 Jun 28;2:26. doi: 10.3389/fnsyn.2010.00026. eCollection 2010.

33.

Association between attention-deficit/hyperactivity disorder and epilepsy in pediatric populations.

Hamoda HM, Guild DJ, Gumlak S, Travers BH, Gonzalez-Heydrich J.

Expert Rev Neurother. 2009 Dec;9(12):1747-54. doi: 10.1586/ern.09.128.

PMID:
19951134
34.

RAGE Control: Regulate and Gain Emotional Control.

Kahn J, Ducharme P, Travers B, Gonzalez-Heydrich J.

Stud Health Technol Inform. 2009;149:335-43.

PMID:
19745492
35.

Comparative clinical responses to risperidone and divalproex in patients with pediatric bipolar disorder.

MacMillan CM, Withney JE, Korndörfer SR, Tilley CA, Mrakotsky C, Gonzalez-Heydrich JM.

J Psychiatr Pract. 2008 May;14(3):160-9. doi: 10.1097/01.pra.0000320115.38434.16.

PMID:
18520785
36.

An expert opinion on methylphenidate treatment for attention deficit hyperactivity disorder in pediatric patients with epilepsy.

Baptista-Neto L, Dodds A, Rao S, Whitney J, Torres A, Gonzalez-Heydrich J.

Expert Opin Investig Drugs. 2008 Jan;17(1):77-84. Review.

PMID:
18095920
37.

Linkage analysis of attention deficit hyperactivity disorder.

Faraone SV, Doyle AE, Lasky-Su J, Sklar PB, D'Angelo E, Gonzalez-Heydrich J, Kratochvil C, Mick E, Klein K, Rezac AJ, Biederman J.

Am J Med Genet B Neuropsychiatr Genet. 2008 Dec 5;147B(8):1387-91.

38.

Attention-deficit/hyperactivity disorder in pediatric patients with epilepsy: review of pharmacological treatment.

Torres AR, Whitney J, Gonzalez-Heydrich J.

Epilepsy Behav. 2008 Feb;12(2):217-33. Epub 2007 Dec 11. Review.

PMID:
18065271
39.

Tolerability of selective serotonin reuptake inhibitors in thirty-nine children under age seven: a retrospective chart review.

Zuckerman ML, Vaughan BL, Whitney J, Dodds A, Yakhkind A, MacMillan C, Raches D, Pravdova I, DeMaso DR, Beardslee WR, Gonzalez-Heydrich J.

J Child Adolesc Psychopharmacol. 2007 Apr;17(2):165-74.

PMID:
17489711
40.

Oxcarbazepine is no more effective than placebo for reducing manic symptoms of bipolar I disorder in children and adolescents.

Macmillan CM, Gonzalez-Heydrich JM.

Evid Based Ment Health. 2007 May;10(2):59. No abstract available.

PMID:
17459990
41.

Prospective open-label pilot trial of mirtazapine in children and adolescents with social phobia.

Mrakotsky C, Masek B, Biederman J, Raches D, Hsin O, Forbes P, de Moor C, DeMaso DR, Gonzalez-Heydrich J.

J Anxiety Disord. 2008;22(1):88-97. Epub 2007 Feb 3.

PMID:
17419001
42.

Psychiatric disorders and behavioral characteristics of pediatric patients with both epilepsy and attention-deficit hyperactivity disorder.

Gonzalez-Heydrich J, Dodds A, Whitney J, MacMillan C, Waber D, Faraone SV, Boyer K, Mrakotsky C, DeMaso D, Bourgeois B, Biederman J.

Epilepsy Behav. 2007 May;10(3):384-8. Epub 2007 Mar 23.

43.

Pharmacological management of a youth with ADHD and a seizure disorder.

Gonzalez-Heydrich J, Weiss M, Connolly M, Wambera K, Jan JE, Plioplys S, Dunn DW, Kratochvil CJ.

J Am Acad Child Adolesc Psychiatry. 2006 Dec;45(12):1527-32. No abstract available.

PMID:
17135999
44.

A comparison of divalproex and oxcarbazepine in aggressive youth with bipolar disorder.

MacMillan CM, Korndörfer SR, Rao S, Fleisher CA, Mezzacappa E, Gonzalez-Heydrich J.

J Psychiatr Pract. 2006 Jul;12(4):214-22.

PMID:
16883146
45.

Depression experience journal: a computer-based intervention for families facing childhood depression.

DeMaso DR, Marcus NE, Kinnamon C, Gonzalez-Heydrich J.

J Am Acad Child Adolesc Psychiatry. 2006 Feb;45(2):158-165. doi: 10.1097/01.chi.0000190353.98570.fe.

PMID:
16429086
46.

No seizure exacerbation from risperidone in youth with comorbid epilepsy and psychiatric disorders: a case series.

Gonzalez-Heydrich J, Pandina GJ, Fleisher CA, Hsin O, Raches D, Bourgeois BF, Biederman J.

J Child Adolesc Psychopharmacol. 2004 Summer;14(2):295-310.

PMID:
15319026
47.

Retrospective study of hepatic enzyme elevations in children treated with olanzapine, divalproex, and their combination.

Gonzalez-Heydrich J, Raches D, Wilens TE, Leichtner A, Mezzacappa E.

J Am Acad Child Adolesc Psychiatry. 2003 Oct;42(10):1227-33.

PMID:
14560173
48.

Use of a computer-based application in a pediatric hemodialysis unit: a pilot study.

Bers MU, Gonzalez-Heydrich J, Demaso DR.

J Am Acad Child Adolesc Psychiatry. 2003 Apr;42(4):493-6.

PMID:
12649637
49.

A case series of eight aggressive young children treated with risperidone.

Cesena M, Gonzalez-Heydrich J, Szigethy E, Kohlenberg TM, DeMaso DR.

J Child Adolesc Psychopharmacol. 2002 Winter;12(4):337-45.

PMID:
12625994
50.

Future of technology to augment patient support in hospitals.

Bers MU, Gonzalez-Heydrich J, DeMaso DR.

Stud Health Technol Inform. 2002;80:231-44.

PMID:
12026132

Supplemental Content

Loading ...
Support Center